生殖药理学的回顾和进展
发布时间:2019-05-09 23:55
【摘要】:正1960年,随着第一个女用复方口服甾体激素避孕药Enovid在美国上市,人类开启了自由掌握生殖权利的新篇章,同时也开辟了药理学中的一个新领域——生殖药理学。20世纪七八十年代,随着一系列甾体激素化合物相继合成,生育调节和激素替代治疗药物的研发成为热点,生殖药理学的学科发展也进入繁盛时期。我国20世纪五六十年代启动了甾体激素用于避孕的研究。1978年,为促进避孕药(具)的发展,成立了上海市计划生育科学研究所。1990年成立了中国药理学会生殖药理学专业委员
[Abstract]:In 1960, with the launch of the first female compound oral steroid hormone contraceptive Enovid in the United States, humans opened a new chapter in the free control of reproductive rights. At the same time, it also opened up a new field of pharmacology-reproductive pharmacology. In the 1970s and 1980s, with the synthesis of a series of steroid hormone compounds one after another, the research and development of fertility regulation and hormone replacement therapy drugs became a hot spot. The subject of reproductive pharmacology has also entered a prosperous period. In the 1950s and 1960s, the research on the use of steroids in contraceptives was launched in China. In 1978, in order to promote the development of contraceptive, Shanghai Institute of Family Planning Science was established. In 1990, the Professional Committee of Reproductive Pharmacology of the Chinese Pharmacological Society was established.
【作者单位】: 中国药理学会生殖药理专业委员会;
【分类号】:R96-1
本文编号:2473191
[Abstract]:In 1960, with the launch of the first female compound oral steroid hormone contraceptive Enovid in the United States, humans opened a new chapter in the free control of reproductive rights. At the same time, it also opened up a new field of pharmacology-reproductive pharmacology. In the 1970s and 1980s, with the synthesis of a series of steroid hormone compounds one after another, the research and development of fertility regulation and hormone replacement therapy drugs became a hot spot. The subject of reproductive pharmacology has also entered a prosperous period. In the 1950s and 1960s, the research on the use of steroids in contraceptives was launched in China. In 1978, in order to promote the development of contraceptive, Shanghai Institute of Family Planning Science was established. In 1990, the Professional Committee of Reproductive Pharmacology of the Chinese Pharmacological Society was established.
【作者单位】: 中国药理学会生殖药理专业委员会;
【分类号】:R96-1
【相似文献】
相关期刊论文 前10条
1 束怀德;甾体激素避孕药[J];生殖与避孕;1980年01期
2 时励英;;应用口服甾体激素避孕药的注意事项[J];中华护理杂志;1987年01期
3 章建华;甾体激素避孕药的不良反应[J];中国医院药学杂志;1994年04期
4 王莲萍;;女用甾体激素避孕药临床应用研究进展[J];临床合理用药杂志;2011年29期
5 雷贞武;赵铀;;女用甾体激素避孕药的临床应用研究进展[J];中国计划生育学杂志;2007年02期
6 周健仪,苏雪芳,李坚,林婵珠;服用甾体激素避孕药后分娩子代与母亲染色体分析[J];中山医学院学报;1981年02期
7 邹辉建,薛士良;甾体激素避孕药与高血压[J];国外医学(计划生育分册);1982年04期
8 杨培娟,宋思,杨秋英,桂幼伦,贺昌海;含不同生物活性的甾体激素避孕药对中国妇女脂代谢的影响[J];中国计划生育学杂志;2000年10期
9 杨培娟;甾体激素避孕药对糖、脂质、蛋白、骨代谢及凝血因子的影响[J];生殖与避孕;1996年02期
10 杨梅丽;甾体激素避孕药药代动力学与安全性[J];中国实用妇科与产科杂志;2001年09期
相关会议论文 前2条
1 雷贞武;;女用甾体激素避孕药的研究进展[A];中华医学会第五届全国计划生育学术会议资料汇编[C];2004年
2 翁梨驹;张震宇;;甾体激素避孕药研究进展[A];第八次全国妇产科学学术会议论文汇编[C];2004年
,本文编号:2473191
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2473191.html
最近更新
教材专著